| Dr Emily Jeannine Cossaboon, AUD | |
|
9420 Key West Ave Ste 310, Rockville, MD 20850 | |
| (301) 315-5888 | |
| (301) 315-5866 |
| Full Name | Dr Emily Jeannine Cossaboon |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 17 Years |
| Location | 9420 Key West Ave Ste 310, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265685671 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 02-0000169 (Delaware) | Secondary |
| 231H00000X | Audiologist | 00991 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ear Nose And Throat Associates Of Butler, Ltd | 7517904543 | 3 |
News Archive
An international gathering of breast cancer survivors at a Sunshine Coast dragon boat regatta will allow researchers to conduct the world's first study into the link between air travel and a swollen arm condition suffered by many breast cancer survivors.
Caring for a patient with sepsis requires walking a treatment tightrope. Clinicians must identify the pathogen that is causing a patient's infection, carefully monitor the patient's response to antibiotics and supportive measures and race against the clock to prevent potential organ failure and death.
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented in the context of a stressful life event were identified as psychogenic in origin when presented by women and organic in origin when presented by men. The study could help explain why there is often a delay in the assessment of women with heart disease.
Aclaris Therapeutics, Inc. today announced positive results from a Phase 2 clinical trial of the Company's lead drug, A-101. In the trial, A-101 demonstrated clinically and statistically significant improvements in clearing seborrheic keratoses (SK), one of the most common types of skin tumors.
Neogenix Oncology announced today that Dr. Luis Diaz of The Johns Hopkins University Hospital will present data from Ensituximab, the company's novel, therapeutic antibody to treat pancreatic and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.
› Verified 6 days ago
| Provider Name | Ear Nose & Throat Associates Of Butler, Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1487685210 PECOS PAC ID: 7517904543 Enrollment ID: O20050412000576 |
News Archive
An international gathering of breast cancer survivors at a Sunshine Coast dragon boat regatta will allow researchers to conduct the world's first study into the link between air travel and a swollen arm condition suffered by many breast cancer survivors.
Caring for a patient with sepsis requires walking a treatment tightrope. Clinicians must identify the pathogen that is causing a patient's infection, carefully monitor the patient's response to antibiotics and supportive measures and race against the clock to prevent potential organ failure and death.
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented in the context of a stressful life event were identified as psychogenic in origin when presented by women and organic in origin when presented by men. The study could help explain why there is often a delay in the assessment of women with heart disease.
Aclaris Therapeutics, Inc. today announced positive results from a Phase 2 clinical trial of the Company's lead drug, A-101. In the trial, A-101 demonstrated clinically and statistically significant improvements in clearing seborrheic keratoses (SK), one of the most common types of skin tumors.
Neogenix Oncology announced today that Dr. Luis Diaz of The Johns Hopkins University Hospital will present data from Ensituximab, the company's novel, therapeutic antibody to treat pancreatic and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Emily Jeannine Cossaboon, AUD 8400 Rosebay Ln Apt 404, Manassas, VA 20109-3818 Ph: (410) 530-1060 | Dr Emily Jeannine Cossaboon, AUD 9420 Key West Ave Ste 310, Rockville, MD 20850 Ph: (301) 315-5888 |
News Archive
An international gathering of breast cancer survivors at a Sunshine Coast dragon boat regatta will allow researchers to conduct the world's first study into the link between air travel and a swollen arm condition suffered by many breast cancer survivors.
Caring for a patient with sepsis requires walking a treatment tightrope. Clinicians must identify the pathogen that is causing a patient's infection, carefully monitor the patient's response to antibiotics and supportive measures and race against the clock to prevent potential organ failure and death.
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented in the context of a stressful life event were identified as psychogenic in origin when presented by women and organic in origin when presented by men. The study could help explain why there is often a delay in the assessment of women with heart disease.
Aclaris Therapeutics, Inc. today announced positive results from a Phase 2 clinical trial of the Company's lead drug, A-101. In the trial, A-101 demonstrated clinically and statistically significant improvements in clearing seborrheic keratoses (SK), one of the most common types of skin tumors.
Neogenix Oncology announced today that Dr. Luis Diaz of The Johns Hopkins University Hospital will present data from Ensituximab, the company's novel, therapeutic antibody to treat pancreatic and colorectal cancers. The presentation is scheduled at the American Society of Clinical Oncology (ASCO) 2011 Gastrointestinal Cancers Symposium to be held January 20-22, 2011 at the Moscone Center in San Francisco, CA, USA.
› Verified 6 days ago
Potomac Audiology Llc Audiologist Medicare: Medicare Enrolled Practice Location: 11300 Rockville Pike, Suite 105, Rockville, MD 20852 Phone: 240-477-1010 Fax: 240-477-1012 | |
Alexandra Lea Yu, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 9420 Key West Ave Ste 310, Rockville, MD 20850 Phone: 301-315-5888 Fax: 301-315-5866 | |
Dr. Carol Kamara, PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11140 Rockville Pike Ste 400, Rockville, MD 20852 Phone: 301-984-2230 | |
Kaitlin E Berry, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 133 Rollins Ave Ste 2, Rockville, MD 20852 Phone: 301-468-7670 Fax: 301-468-7620 | |
Elizabeth Butler, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 121 Congressional Ln Ste 310, Rockville, MD 20852 Phone: 300-146-8055 Fax: 410-315-8823 | |
Seungsun Ellen Park, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 7955 Tuckerman Ln # 1449, Rockville, MD 20854 Phone: 301-299-3717 | |
Dr. Tricia A Terlep, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 11300 Rockville Pike Ste 105, Rockville, MD 20852 Phone: 240-477-1010 Fax: 240-477-1012 |